Company intelligence / Profile preview

Gattefossé

Saint-Priest, Auvergne-Rhône-Alpes, Francegattefosse.com ↗

Ownership: Private
Employees: ~300
Development stage: Commercial

Overview

Gattefossé does not conduct clinical trials or develop its own therapeutics. Its products—primarily lipid-based excipients—are integral to the formulation and bioavailability enhancement of many commercialized drugs worldwide. The company’s innovations have enabled advances in oral, topical, injectable, and transdermal drug formulations. Its products conform to global pharmacopeia standards. It collaborates with pharmaceutical companies throughout all stages from early screening to late-stage development.

Modalities: Small moleculeLipid nanoparticle delivery therapyNanoparticleBiologicDevice
Industry: Chemicals & Materials

Partnerships

Collaborates with global pharmaceutical companies as an ingredient/formulation partner

Beyond the preview

Go deeper on Gattefossé.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gattefossé.